With the annual JPMorgan Healthcare Conference, often called the Superbowl of biotech, officially underway, penny stocks like OncoVista Innovative Therapies, Inc. (OVIT) can somewhat justify why they have gained 443% since their low of 0.06 last week Thursday. Not a peep of news has flowed in over a year from the development stage company that is focused on identifying specific biomarkers ...
13
JAN
JAN
0
Share
